Preview

Teva Pharmaceuticals Case Study

Powerful Essays
Open Document
Open Document
2422 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Teva Pharmaceuticals Case Study
EXTERNAL ENVIRONMENT (General Environment) A company like Teva Pharmaceuticals is subject to all of the factors of the external environment given the nature of its business and global expansion. Pharmaceuticals is an industry where high profits can be achieved, but it is also an extremely challenging business when one considers all of the political/legal aspects involving government regulation and patents. Every country has strict regulation and testing requirements for drugs that affect companies differently depending on their position in the market. Originally, innovative pharmaceutical companies had to obtain patent protection and FDA approval but this would translate to years of protection from the generic competition. Once the Hatch-Waxman Act was put into effect in the United States, this opened the door for generic pharmaceutical companies to legally challenge patented drugs. Generic drugs have an easier time getting FDA approval and under “Paragraph IV” of the act, the first company to file an Abbreviated New Drug Application would enjoy a 6 month exclusivity period where the only two competitors in the market would be the first-mover generic company and the innovative firm. A liberalized market, like in the United States, is much more attractive to the generic pharmaceutical firms because they required less marketing and sales expense as well as no government price regulation. The legal aspect of the pharmaceutical industry ultimately dictates the type of competition that exists within the market. Innovative firms must do a good job of protecting their accomplishments while strategizing in order to deal with the repercussions of the Hatch-Waxman Act. The generic companies on the other hand now have to be vigilant in order to be the first-movers with respect to ANDA, and must be capable of competing with the branded firm and its possible “authorized generic,” along with any other generics companies that are able to compete after the 180-day

You May Also Find These Documents Helpful

  • Powerful Essays

    Teva Pharmacuetical

    • 2882 Words
    • 12 Pages

    The first strategic issue that faces the firm lies at the very root of pharmaceuticals, the decision to be either an innovative or generic pharmaceutical company. Thus…

    • 2882 Words
    • 12 Pages
    Powerful Essays
  • Good Essays

    Enabling mighty competition between commonplace drug treatments and patent-expired fashioned brands is relevant to decreasing pharmaceutical charges and stimulating innovation. However, this mentioned, there are numerous troubling problems surrounding general medicines because of the convenient access to an abundance of illegal generics on the internet breaking the patent ownership and the unregulated companies that produce and supply them. At the same time familiar medicines will have to be approved identical types of depended on drugs, providing the equal fine, safety and efficacy because the normal, that is commonly no longer the case. A conventional drug must endure strict scrutiny before it is licensed and given market approval with the aid of countrywide medicines authorities. In brief, common medicines will have to comply with the same strict standards of great, safety and efficacy as usual pharmaceutical…

    • 490 Words
    • 2 Pages
    Good Essays
  • Satisfactory Essays

    Specific aspects of the Healthcare Reform Act also posed serious threat to Genentech 's business model. The passage of the Biologics Price Competition and Innovation Act allowed for a shortened approval pathway for biogeneric drugs, which would have a significant impact on Genentech, because of the significant costs associated with product development and testing in the industry.…

    • 1095 Words
    • 4 Pages
    Satisfactory Essays
  • Satisfactory Essays

    In 1984, the Hatch-Waxman Act gave generic drug companies greater access to the market for prescription drugs and gave innovator companies greater patent life for branded products. The patent gives a company the sole right to sell the drug while the patent is in effect. When patents or other periods of exclusivity expire, manufacturers can apply to the Food and Drug Administration (FDA) to sell generic versions of the…

    • 70 Words
    • 1 Page
    Satisfactory Essays
  • Powerful Essays

    Prescription drugs whose patents have expired are highly elastic; however, prescription drugs whose patents still exist are highly inelastic. Many consumers will substitute generic brands for drugs that have had their patents expire. These generic drugs can be produced at a much lower cost and yet still contain the active ingredients and FDA approval to their brand name equivalent. As a result, supply increases along with demand and puts downward pressure on price. Because there are no substitutes for patented drugs, consumers have no choice but to pay the higher prices determined by supply and demand…

    • 1538 Words
    • 7 Pages
    Powerful Essays
  • Powerful Essays

    The U.S. market is the world’s largest free-pricing market for pharmaceuticals and has a favorable patent and…

    • 2327 Words
    • 10 Pages
    Powerful Essays
  • Satisfactory Essays

    Final Paper Outline

    • 477 Words
    • 2 Pages

    The generic drug industry covers the marketing and sale of medication containing the same active ingredients and dosages as brand-name drugs manufactured by the pharmaceutical industry. Drugs can be prescribed under their chemical name without specifying a particular pharmaceutical brand or company. A key benefit of generic drugs is that they usually cost a fraction of the price of brand-name drugs. In this context, our company (consulting) is planning to open a franchise of pharmacies that will exclusively provide generic medicines to the customers. We have two investors that have different approaches for the business.…

    • 477 Words
    • 2 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Cvs Competitive Analysis

    • 644 Words
    • 3 Pages

    The market is rapidly growing and changing, forcing competitors to always find new ways to get competitive advantages over the others.…

    • 644 Words
    • 3 Pages
    Satisfactory Essays
  • Good Essays

    References: Bodoni, S. (2011, October 21). Johnson & Johnson, Novartis Face Antitrust Probe on Generics. Retrieved November 17, 2012, from Bloomberg Business Week: http://www.businessweek.com/news/2011-10-21/johnson-johnson-novartis-face-antitrust-probe-on-generics.html…

    • 1350 Words
    • 6 Pages
    Good Essays
  • Better Essays

    Fda Research Paper

    • 2368 Words
    • 10 Pages

    Sauer, C., & Sauer, R. M. (2007, October). Is It Possible to Have Cheaper Drugs and Preserve the Incentive to Innovate? The Benefits of Privatizing the Drug Approval Process. Journal of Technology Transfer, 32(5), 509-524. doi:http://dx.doi.org/10.1007/s10961-007-9036-0…

    • 2368 Words
    • 10 Pages
    Better Essays
  • Better Essays

    Varol, N., Costa-Font, J., and McGuire, A. (2012). Does Adoption of Pharmaceutical Innovation Respond to Changes in the Regulatory Environment? In Applied Economic Perspectives and Policy. Retrieved November 3,…

    • 1054 Words
    • 5 Pages
    Better Essays
  • Satisfactory Essays

    Business

    • 330 Words
    • 2 Pages

    4. Does Pfizer need to change the structure of its organization? If so, what changes are…

    • 330 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    Health Care Reform

    • 1041 Words
    • 5 Pages

    The popular brand name versus the generic battle is a concern in the prescription medicine industry. The uses of brand name drugs have decreased to 20% of total distribution. The expiration of patents of drugs, led to the decrease in brand name distribution. This affects the health care industry in an intense way. This multi-billion dollar industry is affected and patients and physicians must choose whether the generic brand will suffice. Choices by consumer are affected because the cost…

    • 1041 Words
    • 5 Pages
    Good Essays
  • Good Essays

    Genzyme Case Study

    • 745 Words
    • 3 Pages

    1. How does Genzyme’s focus on orphan drugs affect the degree of competition it faces? How does it affect the bargaining power of customers?…

    • 745 Words
    • 3 Pages
    Good Essays
  • Good Essays

    So many medicines protect by patent law, all competitors can make countertrend drugs who have almost some quality…

    • 616 Words
    • 3 Pages
    Good Essays